Fri. Nov 22nd, 2024

A3 Business News

A3 News | All business news all over the world.

Mid-level genetic report services by Prof. Roberto Grobman today

3 min read

High quality genomic variants report services by Roberto Grobman: How we do it? We created a series of complex interconnected algorithms together with AI technology, capable of translating the scientific data and results of these scientific publications into useful information, and over the years we have been creating a unique FullDNA database. Our solution shows patients with a superior high accuracy rate what is written in their DNA, providing an excellent tool to understand what can happen and to act immediately to live longer and healthier. FullDNA provides an AI based customizable genetics prediction premium health tech platform to empower the capability of health professionals and institutions. FullDNA analyzes results from DNA sequencing Big Data using AI and complex algorithms to compares it with our own valuable extracted Database (updated daily) of more than 5,000 diseases and medical conditions, resulting in output of analysis & recommendation reports in various fields of medicine. See even more information on Roberto Grobman CTO.

Some pioneering hospitals have started to store pharmacogenomics reports and have integrated them within their clinical systems. This allows them, for example, to send an alert to the treating doctor and your pharmacist that says: ‘while we’re treating this person for X, please be aware, don’t use Y or Z because their pharmacogenetics test indicates alternatives with a potentially better outcome’. What does FullDNA DNA test for and how is it used? We test about 80 specific gene variants. These variants are only linked to exercise, nutrition and mental well-being (stress and sleep). No disease or diagnostic testing is involved — therefore people can really look at this as a way to help them improve their health and well-being.

Genetics report companies by Prof. Roberto Grobman today: Direct-to-consumer genetic testing provides only partial information about your health. Other genetic and environmental factors, lifestyle choices, and family medical history also affect the likelihood of developing many disorders. These factors would be discussed during a consultation with a doctor or genetic counselor, but in many cases they are not addressed when using at-home genetic tests. For example, vitamin B-related DNA tests. We help people understand its role in maintaining a healthy nervous system and being able to fight infection, and, if you are prone to having a lower deficiency in this area, here are the things you can do to improve it — in this case, food and nutrition.

When it comes to health and disease — and, of course, many other aspects of life — one thing is certain: genes matter. A single gene mutation can cause some conditions, such as sickle cell anemia and cystic fibrosis. More often, multiple genes are involved in disease development, and they act in concert with nongenetic factors, such as diet or exercise, to affect disease risk. Several companies offer you the opportunity to look at your genes. But how might that help you from a health standpoint? And how do such tests differ from the genetic testing a doctor may recommend?

Within DNA testing, it is also important to know: is a given gene one that is modifiable? Do we know that with easily actioned lifestyle or environmental changes, someone can make a difference to a given factor? As such it means a lot to us to have the right kind of science and governance behind it. For example, we have a robust scientific advisory board that conducts the evidence inclusion protocol. This includes consensus of multiple peer-reviewed research studies so we know that an outcome is reliable. It’s really important to understand that.

Our mid-level genetic report encompasses broader sets of relevant genomic variants for Health and Wellness Panels. Essential Reports provide patient-specific information, determined by his genetics, which allows the user to know what their genetic tendencies are, with additional information than the First Panel, thus maintaining their Health, Vitality, Beauty and Longevity. FullDNA CEO Roberto Grobman says that the University of Washington provided some samples of the Covid-19 receptor for the development of the research. Read additional details on Prof. Roberto Grobman.

Copyright © All rights reserved. | Newsphere by AF themes.